Skip to main content

Table 2 Meta-analysis of the studies reporting the association between over-expressed PCAT6 and clinicopathological parameters

From: PCAT6 may be a new prognostic biomarker in various cancers: a meta-analysis and bioinformatics analysis

Clinicopathological parameters Studies Patients Mode OR (95% CI) P value Heterogeneity
I2 (%) P-value
Age (old vs young) 9 736 Random 0.80 [0.51, 1.23] 0.31 53 0.03
Gender (male vs female) 7 267 Fixed 1.84 [1.31, 2.59] 0.0005 0 0.60
Tumor size (big vs small) 6 524 Random 2.73 [1.00, 7.44] 0.05 86  < 0.00001
TNM stage (I + II VS III + IV) 6 211 Random 0.29 [0.09, 0.94] 0.04 86  < 0.00001
Differentiation (well + moderat vs poor) 4 306 Random 1.77 [0.21, 15.11] 0.60 94  < 0.00001
Metastasis (yse vs no) 10 746 Random 5.02 [1.36, 18.57] 0.02 93  < 0.00001
  1. Random Random-effects, Fixed Fixed-effects, OR Odds ratio, CI confidence interval